🔬ResearchStatin Trial for Compensated Cirrhosis Shows Hint of Benefit but Misses Statistical Significance
A phase III study found simvastatin reduced liver decompensation and cancer events in high-risk cirrhosis patients, though the result fell just short of statistical signi…